INTERNATIONAL RESEARCH
Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis
Gaba F, Blyuss O, Tan A, Munblit D, Oxley S, Khan K, Legood R, Manchanda R.
BRCA1/ BRCA2 mutation spectrum analysis in South Asia: a systematic review
Kharel S, Shrestha S, Yadav S, Shakya P, Baidya S, Hirachan S.
Editorial: Hereditary Breast and Ovarian Cancer: Current Concepts of Prevention and Treatment
Grabenstetter A, Lazaro C, Turashvili G. Editorial
Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland
Pallonen, T.AS., Lempiäinen, S.M.M., Joutsiniemi, T.K. et al
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
Yoshida, R.
Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial
Kukafka R, Pan S, Silverman T, et al.
Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals
Shao D, Cheng S, Guo F, et al.
Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations
Tsaousis GN, Papadopoulou E, Apessos A, et al.
Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women
Breast Cancer Association Consortium
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson, M.D., Seock-Ah Im, M.D., Ph.D., Elżbieta Senkus, M.D., Ph.D., Binghe Xu, M.D., Ph.D., Susan M ,et al.
A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu, M.D., Ph.D., Steven N. Hart, Ph.D., Rohan Gnanaolivu, M.S., Hongyan Huang, Ph.D., Kun Y. Lee,et al.
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan, M.D., Pascal Hammel, M.D., Ph.D., Michele Reni, M.D., Eric Van Cutsem, M.D., Ph.D., Teresa Macarulla, M.D., ,et al.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
A.N.J. Tutt, J.E. Garber, B. Kaufman, G. Viale, D. Fumagalli, P. Rastogi,
R.D. Gelber, E. de Azambuja, A. Fielding, J. Balmaña, S.M. Domchek,
K.A. Gelmon, S.J. Hollingsworth, L.A. Korde ,et al.
BRCA1/2 Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome
Le TN, Tran VK, Nguyen TT, et al
Editorial: Hereditary Breast and Ovarian Cancer: Current Concepts of Prevention and Treatment
Grabenstetter A, Lazaro C, Turashvili G.
Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland
Pallonen, T.AS., Lempiäinen, S.M.M., Joutsiniemi, T.K. et al.
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
Reiko Yoshida
Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care A Cluster Randomized Clinical Trial
Kukafka R, Pan S, Silverman T, et al.
Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high‐risk Chinese individuals
Shao D, Cheng S, Guo F, et al.
Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations
Tsaousis GN, Papadopoulou E, Apessos A, et al.
BRCA1/2 Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome
Le TN, Tran VK, Nguyen TT, et al.
Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations. Breast Cancer Res Treat
Singh J, Thota N, Singh S, et al.